These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18318443)

  • 1. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Fransvea E; Angelotti U; Antonaci S; Giannelli G
    Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
    Fransvea E; Mazzocca A; Antonaci S; Giannelli G
    Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
    Mazzocca A; Fransvea E; Dituri F; Lupo L; Antonaci S; Giannelli G
    Hepatology; 2010 Feb; 51(2):523-34. PubMed ID: 19821534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
    Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
    Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L; Sancho P; Bertran E; Fabregat I
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib.
    Lin TH; Shao YY; Chan SY; Huang CY; Hsu CH; Cheng AL
    Clin Cancer Res; 2015 Aug; 21(16):3678-84. PubMed ID: 25977342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
    Wang Q; Yu T; Yuan Y; Zhuang H; Wang Z; Liu X; Feng M
    J Surg Oncol; 2013 Mar; 107(4):422-7. PubMed ID: 22833259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
    Mazzocca A; Fransvea E; Lavezzari G; Antonaci S; Giannelli G
    Hepatology; 2009 Oct; 50(4):1140-51. PubMed ID: 19711426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
    Karmakar S; Das C
    J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.